North Africa Non-Invasive Prenatal Testing Market Analysis & Forecast: 2026-2033
The North Africa non-invasive prenatal testing market is estimated to be valued at USD 4,259 Mn in 2026 and expected to reach USD 7,636 Mn by 2033, witnessing a CAGR of 8.7% over the forecast period (2026-2033).
Noninvasive prenatal testing (NIPT) is an evolving screening procedure for pregnant women. It examines cell free Deoxyribonucleic Acid (DNA) of both fetus and the mother. It provides an analysis of genetic screening using only one tube blood. NIPT provides predictions about the absence or presence of genetic abnormality in the fetus. It involves a simple method of blood withdrawal but presents high quality effectiveness for the detection of trisomy by minimizing the number of performing further invasive testing procedures. NIPT is performed to detect certain genetic abnormalities such as missing or extra copies of X and Y chromosomes, trisomy 18, trisomy 13, and Down syndrome. With technological advancements in the near future, NIPT will be able to detect other genetic abnormalities.
|
Current Event |
Description and its Impact |
|
Regional Healthcare Infrastructure Development |
|
|
Regulatory and Policy Developments |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
In terms of application, the trisomy segment is expected to hold 57.8% share of the market in 2026. Trisomy testing is the most popular type of NIPT in North Africa because it addresses the most common chromosomal problems, like Down Syndrome. Physicians prioritize it because it is clinically important, there is a strong demand from expecting parents, and there are established guidelines. Since it is reliable and well-known, it will be the main method of prenatal genetic screening in 2026.
In terms of end user, the hospitals segment is expected to lead the market with 47.2% share in 2026, because they are still the main places for prenatal care, offering integrated diagnostic services and reliable medical supervision. Expecting mothers prefer testing performed in hospitals because it is safer and comprehensive. Even though independent labs are becoming more popular, hospitals still have the upper hand as they are accessible, have a lot of infrastructure, and get referrals from doctors.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 4,259 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.7% | 2033 Value Projection: | USD 7,636 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Illumina, Inc., Eurofins Scientific, PerkinElmer, Inc., F. Hoffmann-La Roche AG, Natera, Inc., Yourgene Health Plc., Laboratory Corporation of America Holdings (LabCorp), BGI Group, and Quest Diagnostics Incorporated |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
In North Africa, the women are choosing to have children later in life. Older mothers are much more likely to have chromosomal problems like Down syndrome. This makes it essential to find safer and more accurate ways to screen for these problems before birth. Non-invasive prenatal testing (NIPT) solves these problems by giving accurate results without the risks that come with invasive tests. As healthcare providers adjust to changing patient needs, this demographic shift is a major reason for the North Africa Non-invasive Prenatal Testing Market growth.
Families in North Africa are becoming more aware of genetic disorders like trisomy 21, microdeletion syndromes, and sex chromosome abnormalities due to public health campaigns and better access to medical information. Increasingly more individuals are becoming aware of this, which is making pregnant women want to get early and accurate tests to make sure their pregnancies go better. As more people learn about them, the need for advanced screening technologies like NIPT is growing quickly. This increased knowledge is driving up the North Africa Non-invasive Prenatal Testing Market demand, making NIPT the preferred option for prenatal care.
Countries in North Africa, like Egypt, Morocco, and Tunisia, are increasingly marketing themselves as affordable healthcare destinations, drawing in patients from nearby areas and beyond. An influx of international patients is coming to get advanced diagnostic services, which is a great chance for non-invasive prenatal testing (NIPT) providers to add more services and meet demand from other countries. Healthcare facilities can enhance accessibility and accelerate adoption of cutting-edge prenatal screening technologies by using medical tourism. This trend is likely to have a big effect on the North Africa Non-invasive Prenatal Testing Market forecast, which means that it will have a lot of room to grow in the future.
Share
Share
About Author
Komal Dighe is a Management Consultant with over 8 years of experience in market research and consulting. She excels in managing and delivering high-quality insights and solutions in Health-tech Consulting reports. Her expertise encompasses conducting both primary and secondary research, effectively addressing client requirements, and excelling in market estimation and forecast. Her comprehensive approach ensures that clients receive thorough and accurate analyses, enabling them to make informed decisions and capitalize on market opportunities.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
